Literature DB >> 7962441

A sequential analysis of the effect of progesterone on specific sperm functions crucial to fertilization in vitro in infertile patients.

S Oehninger1, C Sueldo, S Lanzendorf, M Mahony, L J Burkman, N J Alexander, G D Hodgen.   

Abstract

The objective of these studies was to evaluate the modulatory effect(s) of progesterone on sperm functions crucial to fertilization in infertile men with abnormal sperm parameters. A prospective, controlled study applying a sequential diagnostic analysis capable of identifying specific dysfunctions of the male gamete was performed. Patients (n = 14) were allocated to the study group if they had a history of infertility of > 1 year duration and after semen evaluation showed teratozoospermia (< 14% normal sperm forms as diagnosed by strict criteria) or terato-asthenozoospermia (< 50% progressive motility). After swim-up separation of the motile sperm fraction, the following functions were assessed with and without previous exposure to progesterone (1.0 micrograms/ml): acrosome reaction (using Pisum sativum agglutinin), hyperactivated motility (using a computerized semen analyser), sperm-zona pellucida binding (in the hemizona assay), sperm-zona pellucida penetration (in a sperm-zona penetration assay), and sperm-oocyte penetration (using the hamster zona-free oocyte/sperm penetration assay). Progesterone did not affect the percentage of acrosome-reacted spermatozoa after 1 or 3 h of incubation. Hyperactivated motility was significantly enhanced by progesterone after 1 h (12 +/- 4 versus 6 +/- 2% in controls; P < 0.02). Although progesterone did not affect sperm-zona binding, it significantly enhanced both sperm-zona pellucida penetration (27 versus 12% in controls; P = 0.03) and sperm-oocyte penetration (15 versus 8% in controls; P < 0.05). Because those sperm functions enhanced by progesterone are crucial to fertilization, the steroid may have value in the treatment of some male-factor patients undergoing assisted reproductive therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962441     DOI: 10.1093/oxfordjournals.humrep.a138702

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Comparative flow cytometric analysis of the human sperm acrosome reaction using CD46 antibody and lectins.

Authors:  J A Carver-Ward; I M Moran-Verbeek; J M Hollanders
Journal:  J Assist Reprod Genet       Date:  1997-02       Impact factor: 3.412

Review 2.  Current Insights and Latest Updates in Sperm Motility and Associated Applications in Assisted Reproduction.

Authors:  Reyon Dcunha; Reda S Hussein; Hanumappa Ananda; Sandhya Kumari; Satish Kumar Adiga; Nagarajan Kannan; Yulian Zhao; Guruprasad Kalthur
Journal:  Reprod Sci       Date:  2020-12-07       Impact factor: 3.060

3.  Progesterone Accelerates the Completion of Sperm Capacitation and Activates CatSper Channel in Spermatozoa from the Rhesus Macaque.

Authors:  Shiho Sumigama; Steven Mansell; Melissa Miller; Polina V Lishko; Gary N Cherr; Stuart A Meyers; Theodore Tollner
Journal:  Biol Reprod       Date:  2015-10-21       Impact factor: 4.285

4.  Effects of hydrogen peroxide on human spermatozoa.

Authors:  S Oehninger; P Blackmore; M Mahony; G Hodgen
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

5.  In vitro assessment of some sperm function following exposure to levonorgestrel in human fallopian tubes.

Authors:  Alexia Hermanny; M Valeria Bahamondes; Francisco Fazano; Nadia M Marchi; Maria Elena Ortiz; Maria Heloisa R R Genghini; Horacio B Croxatto; Luis Bahamondes
Journal:  Reprod Biol Endocrinol       Date:  2012-01-30       Impact factor: 5.211

6.  Lysophosphatidic Acid Improves Human Sperm Motility by Enhancing Glycolysis and Activating L-Type Calcium Channels.

Authors:  Yinlam Li; Li Jin; Yanquan Li; Jianing Qian; Zhengquan Wang; Xiaoguo Zheng; Chong Xie; Xuelian Zhang; Hefeng Huang; Yuchuan Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.